ARTICLE | Company News
Xencor, Novo Nordisk deal
December 22, 2014 8:00 AM UTC
The companies partnered to discover biologic drug candidates for an undisclosed target. The companies will combine multiple XmAb technologies from Xencor, including bispecific and immune inhibitor tec...